Cargando…

2558. Association of Vancomycin-Induced Acute Kidney Injury with Trough Versus AUC Monitoring in Patients Receiving Extended Durations of Therapy

BACKGROUND: Vancomycin (VAN) therapy is associated with an increased risk of AKI. Previous studies suggest that AUC monitoring reduces the risk of AKI, but literature is lacking in patients receiving longer durations of VAN therapy. This study assessed the clinical impact of AUC monitoring on patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pitcock, C Tyler, Wallace, Katie L, Schadler, Aric, Burgess, David, Burgess, Donna R, Cotner, Sarah, VanHoose, Jeremy, Gregory, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676886/ http://dx.doi.org/10.1093/ofid/ofad500.2175

Ejemplares similares

2877. Influence of vancomycin AUC monitoring on acute kidney injury in a large quasi-experimental study of over 3000 patients
por: Gregory, Eric, et al.
Publicado: (2023)

Impact of CLSI Break Point Changes Over the Past Decade on Antimicrobial Susceptibility in Gram-Negative Bacteria
por: Johnson, Wesley, et al.
Publicado: (2021)

Appropriateness of antibiotic use in patients with and without altered mental status diagnosed with a urinary tract infection
por: Anderson, Connor M., et al.
Publicado: (2022)

149. Short vs. Long Course of Antibiotics for Uncomplicated Gram-Negative Bacteremia
por: Go, James, et al.
Publicado: (2019)

1642. Vancomycin AUC(24) Estimation Using First Order Pharmacokinetic Methods in Pediatric Patients
por: Wallace, Katie L, et al.
Publicado: (2023)

164. Performance of ePlex® Blood Culture Identification Panels in Clinical Isolates and Characterization of Antimicrobial Stewardship Opportunities
por: Thomas, Jenni, et al.
Publicado: (2023)

58. Evaluation of a Disease State Stewardship Intervention for Urinary Tract Infections at an Academic Medical Center
por: Xhemali, Xhilda, et al.
Publicado: (2020)

177. Infectious Diseases Consultation Associated with Decreased Mortality in Gram-Negative Bacteremia
por: Bruning, Rebecca, et al.
Publicado: (2023)

1026. Trends in Infective Endocarditis During the Substance Use Disorder Epidemic at an Academic Medical Center
por: Martin, Craig A, et al.
Publicado: (2018)

Impact of an Antimicrobial Stewardship Initiative Focused on Staphylococcus aureus Bacteremia
por: Gregory, Eric, et al.
Publicado: (2017)

1982. A Diagnostic Stewardship Intervention for Clostridioides difficile: Impact of Stool Toxin Testing on Treatment of Adult Inpatients
por: Moss, Jason, et al.
Publicado: (2019)

Impact of Vancomycin Serum Trough Concentrations and Vancomycin AUC/MIC on Vancomycin Response, In-Hospital Outcomes and Acute Kidney Injury in Pediatric Staphylococcus aureus Pneumonia
por: McNeil, Jonathon, et al.
Publicado: (2017)

1327. Vancomycin Dosing by AUC(24)/MIC in Comparison to Traditional Trough Dosing in Office Infusion Centers (OICs)
por: Luu, Quyen, et al.
Publicado: (2020)

2226. Trough- Versus AUC-Based Vancomycin Monitoring for Treatment of Acute Pulmonary Exacerbations of Adult Cystic Fibrosis Patients
por: Smith, Darrell, et al.
Publicado: (2023)

The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients
por: Chen, Jihui, et al.
Publicado: (2021)

220. Acute kidney injury incidence comparison of vancomycin trough-based vs AUC/MIC monitoring at a tertiary care hospital
por: Ruiz Gaviria, Rafael E, et al.
Publicado: (2022)

Educational Resource Review: The case for AUC dosing of vancomycin
Publicado: (2020)

775. Comparison of Initial Vancomycin Costs and Target Attainment Between Trough- and 24-Hour Area Under the Concentration–Time Curve (AUC24)-Guided Dosing
por: Laurent, David, et al.
Publicado: (2019)

Implementation of a Vancomycin AUC Monitoring Program: Peaks and Pitfalls
por: Kassamali, Zahra, et al.
Publicado: (2017)

1090. Does calculation method matter for targeting vancomycin AUC?
por: Chang, Jack, et al.
Publicado: (2021)

1097. A Comparison of Area-Under Curve (AUC)-Guided vs Trough-Guided Monitoring of Vancomycin and Its Impact on Nephrotoxicity: A Systematic Review and Meta-analysis
por: Lim, Ashley Shiyuan, et al.
Publicado: (2021)

Vancomycin trough level and loading dose
por: Tuon, Felipe Francisco, et al.
Publicado: (2018)

2436. Use of Piperacillin/Tazobactam vs. Cefepime or Carbapenem for Infections Due to Serratia, Citrobacter, or Enterobacter
por: Go, James, et al.
Publicado: (2018)

1570. Association Between Vancomycin Area Under the Curve (AUC) and Nephrotoxicity
por: Poston-Blahnik, Anna, et al.
Publicado: (2019)

Different Vancomycin Immunoassays Contribute to the Variability in Vancomycin Trough Measurements in Neonates
por: Samardzic, Janko, et al.
Publicado: (2016)

The Whole Price of Vancomycin: Toxicities, Troughs, and Time
por: Jeffres, Meghan N.
Publicado: (2017)

1568. The Pharmacodynamic–Toxicodynamic Relationship of AUC and CMAX in Vancomycin-Induced Kidney Injury
por: Avedissian, Sean N, et al.
Publicado: (2019)

1107. Vancomycin AUC Dosing: Is One Concentration in the Hand Worth Two in the Bush?
por: Spivey, Justin, et al.
Publicado: (2021)

599. Association between Vancomycin AUC and Clinical Failure in Patients with Streptococcal Bacteremia
por: Aycock, Anna C, et al.
Publicado: (2022)

E.commerce economics /
por: VanHoose, David D.
Publicado: (2003)

1571. Evaluation of a Single Post First Dose Vancomycin Level to Achieve a Goal Vancomycin AUC
por: Hurley, Evan, et al.
Publicado: (2019)

Primary lymphoma of bone: a population-based study of 2558 patients
por: Liu, Chen-Xin, et al.
Publicado: (2020)

349. The impact of Vancomycin dosing by area under the curve over minimal inhibitory concentration (AUC/MIC) versus Trough levels on cumulative Vancomycin dosage and incidence of Acute Kidney Injury (AKI) in patients admitted to intensive care units (ICU)
por: Sahu, Aniruddha, et al.
Publicado: (2023)

1328. Vancomycin exposure and utilization following implementation of an AUC-guided monitoring guideline in children
por: Quraishi, Ruquaya, et al.
Publicado: (2020)

Elevated Vancomycin Trough Concentration: Increased Efficacy and/or Toxicity?
por: Elyasi, Sepideh, et al.
Publicado: (2014)

In Outpatients Receiving Parenteral Vancomycin, Dosing Adjustments Produced by Area Under the Curve-Based and Trough-Based Monitoring Differ Only at the Extremes of the Therapeutic Trough Range
por: Shi, Yufei, et al.
Publicado: (2023)

Therapeutic drug monitoring of vancomycin by AUC(τ)-MIC ratio in patients with chronic kidney disease
por: Khoei, Ahmad, et al.
Publicado: (2019)

Evaluation of traditional initial vancomycin dosing versus utilizing an electronic AUC/MIC dosing program
por: Mcgrady, Kerri A., et al.
Publicado: (2020)

117 Evaluating Predicted vs. Actual Vancomycin Pharmacokinetic Target Attainment Using AUC Dosing
por: Boyd, Allison N, et al.
Publicado: (2022)

Characteristics and calculations of paired vancomycin measurements for determination of 24-h area-under-curve (AUC)
por: Deng, Yutao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_86nri7nhu0kl9cd4ikcmte2dsv